2025 CDSCO Medical Device Registration Guide: Process, Requirements & Pitfalls

The Central Drugs Standard Control Organization (CDSCO) is India’s national regulatory authority, functioning under the Ministry of Health and Family Welfare (MoHFW). It is the primary body responsible for the regulation of drugs, cosmetics, and medical devices in India. For medical devices, CDSCO plays a role similar to the US FDA or the EU’s regulatory bodies, ensuring that only safe, effective, and quality-assured products reach patients. The regulatory framework is governed by the Medical Devices Rules (MDR), 2017, which were updated in 2024 to expand the scope, refine the classification, and strengthen compliance standards. These rules have moved India closer to global harmonization, providing clarity for both domestic and foreign manufacturers.

1. The scope of the CDSCO regulation covers:

• Medical devices: including stents, orthopedic implants, surgical instruments, and diagnostic
  equipment.
• In-vitro diagnostics : such as blood glucose monitors, pregnancy kits, and laboratory
  analyzers.
• Medical software: when classified as a device, including AI-based diagnostic platforms and
  health-monitoring applications.

By regulating approval pathways, conducting audits, and enforcing compliance, CDSCO ensures patient safety while enabling med-tech innovation. For companies looking to enter India’s fast-growing healthcare market, understanding CDSCO’s role is the first step to successful registration and commercialization.

2. Classify Your Medical Device Correctly

CDSCO uses a risk-based classification:

• Class A (Low risk): Thermometers, bandages
• Class B (Low-moderate risk): Needles, suction equipment
• Class C (Moderate-high risk): Orthopedic implants, ventilators
• Class D (High risk): Heart valves, stents

Pitfall to Avoid:

Incorrect classification results in incorrect forms, fees, and delays. For borderline cases,
consult a regulatory expert or refer to CDSCO’s official classification guidance.

Link –Book a No Obligation – Free Classification of Medical Device as per CDSCO published list.

4. Appoint a Valid Indian Authorized Agent (AIA)

Foreign manufacturers are not allowed to apply for CDSCO registration or import licenses directly. To sell or import devices in India, they must appoint an Indian Authorized Agent (AIA) to represent them before the regulator. The AIA acts as the official liaison between CDSCO and the overseas manufacturer.

An Indian Authorized Agent must meet certain regulatory conditions, including:

• Valid Wholesale License (Form 20B/21B) issued under the Drugs and Cosmetics Act Or a Valid Medical Device
  License (FORM 41/42)
• Registered office in India with adequate infrastructure.
• Qualified technical staff with a relevant background in life sciences, pharmacy or regulatory affairs.
• Experience with regulatory filings and knowledge of CDSCO procedures.

Why the Right AIA Matters

Your AIA does much more than just file paperwork. Their responsibilities include:

• Submit applications via the CDSCO Sugam Portal.
• Handling all CDSCO correspondence and responding to queries.
• Maintaining regulatory records, safety reports, and complaint files.
• Supporting license renewals, variations, and post-market obligations.

Best Practices in Choosing an AIA

Pick an AIA that also offers regulatory consulting, not just representation. This ensures guidance on classification,
dossier preparation, and compliance strategy.

Pitfall to Avoid:

Choosing an agent with no regulatory experience. Beyond paperwork, a good Indian Authorized Agent ensures smooth CDSCO communication, compliance, and record-keeping.

5. Prepare a Complete Technical Documentation Set

A strong technical dossier is crucial for obtaining CDSCO approval. The exact requirements vary by device class, but the following documents are commonly required:

• Device Master File : Device description, intended use, specifications, risk analysis, and
  performance data.
• Plant Master File: Details of the manufacturing facility, processes, and quality systems.
• ISO 13485 Certificate:Proof of compliance with international quality management standards.
• Free Sale Certificate : Evidence that the device is approved and marketed in the country of
  origin.
• Clinical Evaluation Reports (for Class C/D): ●Data supporting safety and effectiveness.
• Device Labeling & IFU: Packaging, labeling, and instructions for use.

Formatting Tips:

• All documents must be in English, and some may require notarization or legalization.
• Maintain a digital archive for easy access during audits or inspections.

Pitfall to Avoid:

Submitting outdated or incomplete certificates. Always ensure your dossier is current and properly legalized.

Register on the CDSCO Sugam Portal

The Sugam Portal is CDSCO’s online system for submitting applications and tracking approvals. An account must be created by either the Indian manufacturer or the Authorized Indian Agent representing a foreign manufacturer. This account becomes the official communication channel with CDSCO.

Tips to Avoid Account Rejections:

• Upload valid incorporation documents, licenses, and authorization letters in the correct format.
• Ensure names, addresses, and authorization letters exactly match supporting documents.
• Assign roles carefully having both an admin and an applicant role prevents access issues later.

Technical Guidance:

• Use Google Chrome or Mozilla Firefox with pop-ups enabled.
• Upload documents in PDF format within the size limits.
• Keep files organized and named consistently for quick access during submission.

Pitfall to Avoid:

Errors in documentation or mismatched details can lead to rejections, delaying the registration timeline.

7. Submit the Application Using the Correct CDSCO Forms

Once registered on the Sugam Portal, the next step is to submit your application using the correct CDSCO forms. Choosing the right form and correctly categorizing your device are critical for a smooth approval process.

Key CDSCO Forms:

• Form MD-14: Application for an import license to market medical devices or IVDs in India.
• Form MD-15: The import license is issued by CDSCO once the application is approved.

Device Category Selection:

Applicants must carefully choose the correct device class (A, B, C, or D) and identify whether products can be grouped (e.g., multiple models under the same family) to avoid duplicate filings.

Common Submission Errors to Avoid:

• Uploading documents in the wrong file format or size leads to rejections.
• Misclassifying devices can result in delays, resubmissions, or even rejection of the application.
• Submitting incomplete dossiers without proper labeling, IFU, or legalizations.

8. Respond Quickly to CDSCO Clarifications

Once your application is submitted, CDSCO reviews it and may raise queries or deficiency letters through the Sugam Portal. These are the most common causes of delays.

What to Expect:

• CDSCO first checks the completeness of documents.
• Queries are raised if details are missing, outdated, or unclear.
• Each query can extend the approval timeline, so fast action is critical.

Best Practices:

• Assign a dedicated regulatory contact to monitor the portal.
• Maintain a pre-response checklist for common issues (ISO certificate, FSC, labeling, etc.).
• Respond promptly and accurately to avoid pushing back timelines.

Pitfall to Avoid:

Delayed or incomplete responses. CDSCO may suspend or reject applications if clarifications
aren’t addressed in time.

9. Obtain the CDSCO Import License (Form MD-15)

Once clarifications are resolved, CDSCO issues the Import License (Form MD-15). This license specifies the manufacturer’s details, device name(s), and authorized Indian agent.
The license is currently valid for 5 years, after which it must be renewed. However, holding the license is not the end of compliance obligations. Importers and agents are responsible for:

• Maintaining ongoing compliance with CDSCO regulations.
• Handling recalls or complaints related to device safety or quality.
• Keeping records updated if there are changes in the manufacturer, labeling, or distribution.
• Applying for timely renewals to avoid disruptions in import approvals.

10. Avoid These CDSCO Registration Pitfalls

Even after meeting all formal requirements, many applications face delays or rejections due to common mistakes.

Real-World Mistakes:

• Submitting incomplete or outdated documents: Expired ISO 13485 certificates missing FSC or not
  notarizing documents.
• Using an unqualified Indian agent: Agents without regulatory knowledge may mishandle applications.
• Incorrect classification assumptions: Misjudging whether a device falls under Class B, C, or D
  leads to rework.
• Ignoring post-market obligations: Failing to report complaints, recalls, or renewals risks
  non-compliance.

How to Prevent Them:

• Maintain an updated document checklist before submission.
• Select a qualified Authorized Indian Agent (AIA) with regulatory expertise.
• Verify device classification against CDSCO’s official guidance.
• Assign a compliance officer to track post-market responsibilities.

11. Plan for Post-Approval Compliance

Approval is just the start. You must ensure ongoing compliance through:

• Periodic Safety Update Reports: Regularly submit safety data to CDSCO.
• Adverse Event Reporting: Promptly report device-related incidents or risks.
• Timely License Renewal: Import licenses (Form MD-15) are valid for 5 years and must be renewed
  before expiry.
• Consequences of Non-Compliance: CDSCO may suspend your license, impose import bans or initiate
  regulatory action.

12. Calculate Expected Timelines and Costs

Processing Timelines

• Class A: 30–45 days (low risk, minimal review).
• Class B: 60–90 days (depends on document completeness/clarifications).
• Class C/D: 90–180+ days (high risk, detailed scrutiny, clinical data may be required).

Cost Breakdown

• Government fees: Vary by device class higher for advanced classes.
  • Class A – One Site – USD 1000 + USD 50 (each distinct medical Device)
  • Class B – One Site – USD 2000 + USD 1000 (each distinct medical Device)
  • Class C or D – One Site – USD 3000 + USD 1500 (each distinct medical Device)

  Link to Fees Page-

• Authorized Indian Agent fees: Essential for foreign manufacturers.
• Translation & legalization charges: For certificates and regulatory documents in English.

Pitfall to Avoid:

Don’t overpromise launch timelines delays usually result from incomplete documents or wrong classification, not CDSCO.

13. Evaluate Market Entry Timing and Strategy

CDSCO approvals take months, so begin the process early—even before onboarding distributors. Align registration timelines with product launches or government tenders to avoid missed opportunities. Instead of registering just one model, build a pipeline of devices to streamline future approvals and accelerate expansion. Early registration also strengthens your position in distributor negotiations, as approvals in hand demonstrate commitment and reduce risks.

Pitfall to Avoid:

Waiting until a sales opportunity arises. Approvals are not immediate, and delays may cause you to miss tenders or lose a competitive advantage in the Indian market.

14. Leverage Regulatory Support to Simplify the Process

Partnering with a consultant experienced in CDSCO medical device regulations can save foreign manufacturers significant time, effort, and risk.

Key Benefits

• Faster Submissions: Experts streamline dossier preparation and application filing.
• Reduced Errors: Consultants ensure documents meet CDSCO standards avoiding costly rejections.
• Local Liaison with Authorities: Having a trusted partner in India helps bridge communication
  with regulators.

Services Foreign Companies Can Outsource

• Classification Analysis: Determining the correct device class under Indian regulations.
• Document Review: Checking technical files for completeness and compliance.
• Application Filing: Submitting applications to CDSCO on your behalf.
• Authorized Agent Representation: Acting as your local point of contact for CDSCO.

Pitfall to Avoid:

Attempting to handle the CDSCO process without proper regulatory knowledge often leads to delays, rejections, or compliance risks. Professional support ensures smoother approvals and minimized risk.